Calnexin bridges the gap toward a pan-fungal vaccine

Area of Science:

• Immunology
• Mycology
• Vaccinology

Background:

• Global incidence of fungal infections is increasing.
• Effective vaccines are needed to combat diverse fungal pathogens.
• CD4 T cell responses are critical for adaptive immunity.

Purpose of the Study:

• To identify potential targets for broad-spectrum antifungal vaccines.
• To investigate the role of CD4 T cell responses in antifungal immunity.
• To explore conserved epitopes that elicit protective immune responses against fungi.

Main Methods:

• Antigen identification and characterization.
• T cell response assays (e.g., ELISpot, flow cytometry).
• Fungal challenge models in mice.

Main Results:

• Calnexin was identified as a target antigen for CD4 T cell responses.
• A conserved epitope on calnexin triggered T cell responses against multiple fungal species.
• Immune responses targeting calnexin conferred heterologous antifungal immunity.

Conclusions:

• Calnexin is a promising target for developing vaccines against multiple fungal diseases.
• Convergent T cell responses to conserved epitopes can provide broad antifungal protection.
• This research paves the way for next-generation antifungal vaccines.